AGONISTS OF THE NOGO-A S1PR PATHWAY FOR THE TREATMENT OF GLIOBLASTOMA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15546662

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of an extracellular domain of Nogo selected from Nogo-A delta 20 and Nogo-66 for the treatment of glioblastoma, particularly by intravenous or intrathecal administration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT ZURICH8006 ZÜRICH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FREI, Karl Jona, CH 7 82
HOERSTRUP, Simon Zurich, CH 7 4
SCHWAB, Martin Zurich, CH 19 110
WACKER, Andrin Uster, CH 1 0
WALCHLI, Thomas Zurich, CH 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation